We are live on
!
Find out more
Mackenzie Financial Portfolio holdings
AUM
$83.3B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+0.31%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$73.4B
AUM Growth
+$1.52B
(+2.1%)
Cap. Flow
+$2.56B
Cap. Flow
% of AUM
3.49%
Top 10 Holdings %
Top 10 Hldgs %
23.07%
Holding
1,814
New
240
Increased
756
Reduced
535
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$329M |
| 2 |
Descartes Systems
DSGX
|
+$312M |
| 3 |
Amazon
AMZN
|
+$283M |
| 4 |
MSCI
MSCI
|
+$245M |
| 5 |
Microsoft
MSFT
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$202M |
| 2 |
CAE Inc. Common Shares
CAE
|
+$195M |
| 3 |
Royal Bank of Canada
RY
|
+$165M |
| 4 |
Trane Technologies
TT
|
+$155M |
| 5 |
S&P Global
SPGI
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.87% |
| 2 | Financials | 22.07% |
| 3 | Industrials | 10.93% |
| 4 | Healthcare | 8.97% |
| 5 | Energy | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
CVS Health
CVS
$133B
| $36.9M | 0.05% |
821,772
+68,144
| +9% | +$3.82M |
|
|
SCHW
252
Charles Schwab
SCHW
$183B
| $36.7M | 0.05% |
495,524
+24,677
| +5% | +$1.85M |
|
253
Commault Systems
CVLT
$4.88B
| $36.6M | 0.05% |
242,323
-449,657
| -65% | -$72.4M |
|
254
Everest Group
EG
$14.5B
| $36.5M | 0.05% |
100,753
+2,793
| +3% | +$1.05M |
|
255
General Motors
GM
$80.4B
| $36.4M | 0.05% |
682,570
-76,488
| -10% | -$4.01M |
|
256
Carrier Global
CARR
$51B
| $36M | 0.05% |
527,146
-61,850
| -11% | -$4.67M |
|
257
Arthur J. Gallagher & Co
AJG
$64.1B
| $35.6M | 0.05% |
125,588
+20,437
| +19% | +$5.95M |
|
258
Lowe's Companies
LOW
$117B
| $35.5M | 0.05% |
143,672
-7,326
| -5% | -$1.96M |
|
259
Equinox Gold
EQX
$7.06B
| $35.3M | 0.05% |
7,008,149
+2,093,437
| +43% | +$11.7M |
|
260
AstraZeneca
AZN
$263B
| $34.7M | 0.05% |
265,019
+112,252
| +73% | +$15.7M |
|
261
ATS Corp
ATS
$2.64B
| $34.5M | 0.05% |
1,131,921
+221,816
| +24% | +$6.73M |
|
262
PG&E
PCG
$38.3B
| $34.4M | 0.05% |
1,703,979
+314,119
| +23% | +$6.39M |
|
263
ASML
ASML
$626B
| $34.4M | 0.05% |
49,568
-2,547
| -5% | -$1.83M |
|
264
NXP Semiconductors
NXPI
$57.8B
| $34.1M | 0.05% |
163,989
+12,845
| +8% | +$2.92M |
|
265
Maravai LifeSciences
MRVI
$969M
| $33.7M | 0.05% |
6,182,716
-180,696
| -3% | -$1.16M |
|
266
Edison International
EIX
$28.2B
| $33.6M | 0.05% |
421,012
+47,267
| +13% | +$3.95M |
|
267
Sensata Technologies
ST
$6.74B
| $33.4M | 0.05% |
1,217,602
+17,575
| +1% | +$571K |
|
268
Bristol-Myers Squibb
BMY
$133B
| $33.1M | 0.05% |
585,766
+267,843
| +84% | +$15M |
|
269
AngloGold Ashanti
AU
$40.1B
| $33.1M | 0.05% |
1,434,626
-88,708
| -6% | -$2.32M |
|
|
NGD
270
DELISTED
New Gold Inc
NGD
| $33.1M | 0.05% |
13,251,786
-1,747,750
| -12% | -$4.82M |
|
271
Hudbay
HBM
$10.1B
| $33.1M | 0.05% |
4,079,147
-854,747
| -17% | -$7.67M |
|
272
Nutanix
NTNX
$16B
| $32.8M | 0.04% |
536,834
-66,419
| -11% | -$4.34M |
|
273
Advanced Micro Devices
AMD
$776B
| $32.8M | 0.04% |
271,398
+73,062
| +37% | +$10.5M |
|
274
SPDR Gold Trust
GLD
$131B
| $32.5M | 0.04% |
134,200
+25,950
| +24% | +$6.38M |
|
275
Cigna
CI
$73.7B
| $32.3M | 0.04% |
117,005
-1,988
| -2% | -$634K |
|
Similar funds
Mackenzie Financial's Q4 2024 Portfolio in Review
As of Q4 2024, Mackenzie Financial held 1,814 positions worth $73.4B, up 2.1% from $71.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Mackenzie Financial deployed $2.56B of net new capital in Q4 2024, opening 240 new positions and adding to 756 existing holdings. Its largest new stake was South Bow Corp: 1,138,044 shares worth $26.8M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Becton Dickinson, an estimated $202M trimmed.
- Mackenzie Financial's largest Q4 2024 buy was South Bow Corp: 1,138,044 shares worth $26.8M.
- Mackenzie Financial added most to Apple in Q4 2024, an estimated $329M increase.
- Mackenzie Financial's biggest Q4 2024 reduction was Becton Dickinson, cutting an estimated $202M.
- Mackenzie Financial fully exited Axonics, Inc. Common Stock in Q4 2024, selling an estimated $87.2M.
- Mackenzie Financial's ten largest holdings make up 23% of its $73.4B portfolio in Q4 2024.
- Mackenzie Financial opened 240 new positions and closed 124 in Q4 2024.
- Mackenzie Financial's portfolio value rose 2.1% quarter-over-quarter to $73.4B.
Based on Mackenzie Financial's 13F filing for Q4 2024, filed 14 Feb 2025.